About this Journal Submit a Manuscript Table of Contents
Lymphoma
Volume 2012 (2012), Article ID 290685, 10 pages
http://dx.doi.org/10.1155/2012/290685
Review Article

Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors

1Epigenomic Medicine, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, VIC 3004, Australia
2Department of Pathology, The University of Melbourne, Parkville, VIC 3010, Australia

Received 30 May 2012; Accepted 23 June 2012

Academic Editor: Vincent Ribrag

Copyright © 2012 Annabelle L. Rodd et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Annabelle L. Rodd, Katherine Ververis, and Tom C. Karagiannis, “Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors,” Lymphoma, vol. 2012, Article ID 290685, 10 pages, 2012. doi:10.1155/2012/290685